SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001689375-23-000059
Filing Date
2023-09-05
Accepted
2023-09-05 16:29:45
Documents
2
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_169394576964484.html 3  
1 FORM 3 wf-form3_169394576964484.xml 3 1724
2 POWER OF ATTORNEY ex-24.htm EX-24 4367
  Complete submission text file 0001689375-23-000059.txt   7613
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARGO THERAPEUTICS, INC. 1900 ALAMEDA DE LAS PULGAS, SUITE 350 SAN MATEO CA 94403
Business Address
Chapman Gina (Reporting) CIK: 0001989220 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40969 | Film No.: 231236177